580P AT1412, a patient-derived CD9 antibody promotes tumour immune infiltration and induces tumour rejection

Autor: Schotte, R., Villaudy, J., Kedde, M., Pos, W., Wagner, K., Go, D., Fatmawati, C., Moiset, G., Yasuda, E., Cercel, M., Frankin, E., van Hal-van Veen, S., van Helden, P., Verdegaal, E.M.E., van Eenennaam, H., van der Burg, S.H., Spits, H.
Zdroj: In Annals of Oncology September 2020 31 Supplement 4:S492-S492
Databáze: ScienceDirect